Porcilis® PCV M Hyo-Field efficacy studies from six European and three Asian countries.

ĐoạnĐịnh dạng 16px

Porcilis® PCV M Hyo – It’s easy. It’s safe. It works.

Field efficacy studies from six European and three Asian countries.

In six European and three Asian countries, Porcilis® PCV M Hyo field efficacy was compared against a competitor vaccine and a control group.

Results field efficacy studies

Primary observations from the six studies

Porcilis PCV M Hyo:

• Improved average daily gain during the finishing phase

• Reduced the severity of lung lesion scores

• Reduced PCV2 viremia

• Induced a strong PCV2 and Mycoplasma hyopneumoniae humoral and cell mediated response

• Increased revenue per pig

Time to say yes to Porcilis® PCV M Hyo!
It’s easy. It’s safe. It works.

Detail information:Click Here